Product NDC: | 0085-1737 |
Proprietary Name: | Avelox |
Non Proprietary Name: | moxifloxacin hydrochloride |
Active Ingredient(s): | 400 mg/250mL & nbsp; moxifloxacin hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0085-1737 |
Labeler Name: | Schering Plough Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021277 |
Marketing Category: | NDA |
Start Marketing Date: | 20011130 |
Package NDC: | 0085-1737-01 |
Package Description: | 250 mL in 1 BAG (0085-1737-01) |
NDC Code | 0085-1737-01 |
Proprietary Name | Avelox |
Package Description | 250 mL in 1 BAG (0085-1737-01) |
Product NDC | 0085-1737 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | moxifloxacin hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20011130 |
Marketing Category Name | NDA |
Labeler Name | Schering Plough Corporation |
Substance Name | MOXIFLOXACIN HYDROCHLORIDE |
Strength Number | 400 |
Strength Unit | mg/250mL |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |